FDA Biologics (BLA & Biosimilars)Original article
Vaccines and Related Biological Products Advisory Committee October 1, 2026 Meeting Announcement - 10/01/2026
AdComInfluenza virus vaccinesNeutral
AI Analysis
Summary
The FDA's Vaccines and Related Biological Products Advisory Committee convenes on October 1, 2026 to discuss and recommend influenza virus vaccine strains for the 2027 Southern Hemisphere influenza season.
Importance:3/10
Sentiment:
0.00
FDA Advisory CommitteeInfluenza vaccinesStrain selectionSouthern Hemisphere
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on October 1, 2026 3:13 PM